Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026)
Cadrenal Therapeutics (CVKD) recorded Shares Outstanding (Entity) of 3.1 million in Q2 2026, up 54.4% from 2.01 million a year earlier and up 23.6% from the prior quarter.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends
For FY2025, Cadrenal Therapeutics reported Shares Outstanding (Entity) of 2.34 million, up 91.7% from FY2024.
- Annual Shares Outstanding (Entity) has increased for three straight years, with a three-year compound annual growth rate of 62.4% (FY2022 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 1.22 million in FY2024 (+40.5%), 868,227 in FY2023 (+58.9%) and 546,286 in FY2022.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2022.
- On a year-over-year basis, Shares Outstanding (Entity) has increased for 14 consecutive quarters, with growth averaging 61.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 31.3% in Q1 2026 to 91.7% in Q4 2025.
- Per Business Quant, the preceding three quarters came in at 2.51 million (Q1 2026), 2.34 million (Q4 2025) and 2.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,175.39 Bn | 1,143.98 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 639.10 Bn | 557.63 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 502.70 Bn | 475.81 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 376.68 Bn | 331.05 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 304.33 Bn | 268.32 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.75 Bn | 241.43 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.34 Bn | 197.73 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 193.67 Bn | 167.87 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.62 Bn | 119.27 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Cadrenal Therapeutics | 2.88 Mn | -9.73 Mn | - | 3.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.10 Mn |
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 2.34 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 868,227.00 |
| Sep 30, 2023 | 868,227.00 |
| Jun 30, 2023 | 781,556.00 |
| Mar 31, 2023 | 781,556.00 |
| Dec 31, 2022 | 546,286.00 |
| Sep 30, 2022 | 541,819.00 |
| Jun 30, 2022 | 530,026.00 |
| Mar 31, 2022 | 500,025.00 |
API Access
Cadrenal Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();